InVitro International Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 13, 2026	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020
Market Capitalization	2	2	1	1	4	3
Market Cap Growth	-16.18%	73.91%	-11.93%	-61.77%	54.55%	106.76%
Enterprise Value	1	1	0	0	3	1
Last Close Price	0.10	0.10	0.06	0.07	0.17	0.11
PE Ratio	24.85	21.24	838.98	69.53	40.31	50.18
PS Ratio	2.73	2.79	1.64	1.73	3.86	2.27
PB Ratio	1.41	1.45	0.90	1.03	2.71	1.89
P/TBV Ratio	1.42	1.45	0.90	1.03	2.71	1.89
P/FCF Ratio	-	22.98	-	47.34	133.92	-
P/OCF Ratio	22.44	22.98	-	36.42	120.96	-
EV/Sales Ratio	1.58	1.40	0.09	0.32	2.80	1.30
EV/EBITDA Ratio	10.58	15.65	-	-	-	41.86
EV/EBIT Ratio	18.76	16.65	-	-	-	45.87
EV/FCF Ratio	-	11.54	-	8.77	97.31	-
Debt / Equity Ratio	0.22	0.22	0.03	-	0.07	0.08
Debt / EBITDA Ratio	2.81	2.81	1.83	-	-	3.11
Debt / FCF Ratio	3.45	3.45	-	-	3.50	-
Net Debt / Equity Ratio	-0.59	-0.59	-0.78	-0.85	-0.84	-0.80
Net Debt / EBITDA Ratio	-12.81	-12.81	51.39	10.83	48.18	-30.85
Net Debt / FCF Ratio	-9.44	-9.44	18.82	-39.44	-41.73	47.34
Asset Turnover	0.47	0.47	0.52	0.54	0.63	0.76
Inventory Turnover	0.91	0.91	0.98	1.16	1.30	1.30
Quick Ratio	14.18	14.18	16.07	18.82	7.09	6.18
Current Ratio	16.69	16.69	18.57	21.68	7.96	7.15
Return on Equity (ROE)	7.06%	7.06%	0.11%	1.48%	6.96%	3.91%
Return on Assets (ROA)	2.45%	2.45%	-1.04%	-4.64%	-1.06%	1.34%
Return on Invested Capital (ROIC)	14.18%	14.18%	-5.77%	-53.80%	-9.87%	9.53%
Return on Capital Employed (ROCE)	3.70%	3.70%	-1.70%	-8.10%	-1.90%	2.40%
Earnings Yield	4.82%	4.71%	0.12%	1.44%	2.48%	1.99%
FCF Yield	-	4.35%	-4.60%	2.11%	0.75%	-0.89%
Buyback Yield / Dilution	-4.87%	0.15%	-1.98%	-0.87%	-2.10%	-2.91%

Updated Jan 13, 2009. Source: S&P Global Market Intelligence. Standard template. Financial Sources.